Avacta Group Plc (LON:AVCT – Get Free Report)’s share price was up 13.2% during mid-day trading on Thursday . The stock traded as high as GBX 68 ($0.86) and last traded at GBX 66.51 ($0.84). Approximately 5,891,759 shares were traded during mid-day trading, an increase of 133% from the average daily volume of 2,530,845 shares. The stock had previously closed at GBX 58.75 ($0.74).
Avacta Group Price Performance
The firm’s fifty day moving average price is GBX 44.51 and its two-hundred day moving average price is GBX 68.61. The company has a quick ratio of 4.96, a current ratio of 0.62 and a debt-to-equity ratio of 191.87. The stock has a market capitalization of £238.78 million, a PE ratio of -652.78 and a beta of 1.22.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
See Also
- Five stocks we like better than Avacta Group
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
